On March 24, 2026, Huzhou Enmeidi Artificial Intelligence Technology Co., Ltd. (referred to as "Enmeidi"), a developer of intelligent medical devices, announced the completion of a new round of strategic financing. The financing was jointly invested by Lion City Capital and Lude Medical, with the specific amount undisclosed.

Enmeidi was established on April 30, 2025, and is a high-tech enterprise focused on the research and development of intelligent medical devices. The company mainly engages in the R&D, production, and sales of intelligent medical device products, and provides integrated solutions for intelligent medical data analysis. Enmeidi is committed to enhancing the intelligence level of medical equipment through artificial intelligence technology, providing more efficient and precise medical services for medical institutions and patients.

This strategic investment was jointly completed by Lion City Capital and Lude Medical. Lion City Capital is an investment institution focused on the healthcare sector, with a long-term interest in the development of the intelligent medical device industry. Lude Medical is a company with rich experience and resources in the medical equipment field, and this investment will further promote Enmeidi's R&D and market expansion in the intelligent medical device sector.

The founder of Enmeidi stated that this financing will mainly be used for expanding the company's R&D team, developing new products, and market promotion. The company will continue to deepen its efforts in the intelligent medical device field, driving innovation and application in medical technology, and contributing to the improvement of medical service quality.

For more information about the companies mentioned in the article, please click the link: Enmeidi

This article was generated by Xiao Ou AI based on data from Yiou. If you have any questions or suggestions, please feel free to contact us through the contact information at the bottom of the website.